Moleculin Biotech, Inc.
MBRX
$2.41
-$0.06-2.43%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/5/2026
-
TipRanks
6/5/2026
-
Globe Newswire
6/4/2026
-
Globe Newswire
5/29/2026
-
Globe Newswire
5/22/2026
-
TipRanks Financial Blog
5/21/2026
-
Globe Newswire
5/15/2026
-
SeekingAlpha.com: All News
5/15/2026
-
Globe Newswire
5/13/2026
-
TipRanks Financial Blog
5/13/2026
-
Globe Newswire
5/12/2026
-
TipRanks Financial Blog
5/12/2026
-
Globe Newswire
Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin
5/8/2026
-
Globe Newswire
4/23/2026
-
Globe Newswire
4/21/2026
-
Globe Newswire
4/15/2026
-
TipRanks Financial Blog
4/7/2026
-
Globe Newswire
3/30/2026
-
SeekingAlpha.com: All News
3/27/2026
-
TipRanks Financial Blog
3/27/2026
-
TipRanks Financial Blog
3/27/2026
-
PR Newswire
3/27/2026
-
CNW Group - News Releases
3/24/2026
-
TipRanks Financial Blog
3/24/2026
-
TipRanks Financial Blog
3/23/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 14, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
713 300 5160
Address
5300 Memorial Drive
Houston, TX 77007
Houston, TX 77007
Country
Year Founded
Business Description
Sector
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is...
more